Total Funding
60
48
Total FundingSeed raised
Growth Score
-6 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
119171
Respirogen features a device technology provides oxygen independent from damaged lungs like Acute respiratory distress syndrome.
Mark Borden: Co-Founder and Chief Scientific Officer- Bob Scribner: CEO
About the Company
Respirogen is a biotechnology company that features a device technology that provides oxygen-independent from damaged lungs like Acute respiratory distress syndrome. Its medical device is designed for several triggers, including pneumonia or trauma.
The company was founded in 2017 and headquartered in Boulder, Colorado.
